You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BRVE Award Disclosure
Rickey James Paul · SEC Form 4 · Filed Aug 7, 2026
Award
Calculated transaction value
$0
Rickey James Paul Chief Financial Officer
BRVE
Braveheart Bio, Inc.
BRVE
Transaction date
Aug 5, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 2 days later
BRVE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 300,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001470831-26-000804
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$499.99K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Braveheart Bio, Inc. BRVE | Buy | Aug 7, 2026 | $499.99K |
| Braveheart Bio, Inc. BRVE Current | Award | Aug 5, 2026 | $0 |